We use privacy-friendly analytics. Read our privacy policy.

Compound Profile

Catuaba

Catuaba has limited preclinical CNS research and no robust human clinical evidence.

Use extra caution — Review medications, pregnancy status, chronic conditions, and clinician guidance before use. Details

Last reviewed: Report a correctionProfile-wide ·C Limited
Catuaba monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Safety evidence: limited human evidence for a multi-herb product, not standalone catuaba.
Profile context
dopaminergic/CNS pathways (proposed)
Next steps

Continue reading

Quick stats

Evidence level
Limited evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Interaction risk
Best for
Dopaminergic/CNS Pathways (Proposed)

Safety

Safety & Cautions

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Safety evidence
limited human evidence for a multi-herb product, not standalone catuaba
Who should avoid this?
No specific evidence-backed contraindication is documented for this profile. This is not the same as established safety.
Talk to a professional if
you use relevant medications, you are pregnant or breastfeeding, surgery is planned or recent, you have a condition named in this safety summary.

A 28-day healthy-volunteer study reported no severe reactions or laboratory changes for a combination containing Trichilia catigua; species-specific, pregnancy, breastfeeding, surgery, liver, kidney, and interaction safety remain insufficient.

Evidence Summary

Profile-wide ·C Limited

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mapped — CNS Stimulatory/Anxiolytic Signaling (Proposed) · Neurotransmitter Modulation (Uncertain) · Neurotransmitter Modulation

Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note available — Review medications, pregnancy status, chronic conditions, and clinician guidance before use.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Limited evidence

Catuaba has a limited evidence rating.

General wellnessGeneral wellness
Effects
1
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials

How Catuaba Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Catuaba Works

How Catuaba WorksCatuaba acts on biological target pathways via neurotransmitter (modulation), leading to dopaminergic/cns pathways (proposed).CatuabaBiological TargetBiological pathwayNeurotransmitterModulationDopaminergic/Cns Pathways (Proposed)Observable outcomeDopamineModulation
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form
standardized extract capsule
No standardized dose
Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • CNS Stimulatory/Anxiolytic Signaling (Proposed)
  • Neurotransmitter Modulation (Uncertain)
  • Neurotransmitter Modulation

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Catuaba evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Sourcing options disabled for safety

Direct product recommendations and affiliate links are suppressed for this compound due to its high caution or needs-review safety classification.

Evaluate the safety checks, contraindications, and potential medication interactions above under clinician supervision before use.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?